Venture capital

Record venture capital and heated deal environment propelled biotechnology industry forward in 2007, says Ernst & Young’s biotech report for last year.

Ireland’s largest-ever healthcare venture capital fund is making its optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits. So what’s happening?

Financing high-tech start-ups is not getting any easier, but a pioneering UK biotech may have an escape route

The UK’s private equity and venture capital industry is bracing itself for an economic slowdown, according to new research.

The European Commission has proposed measures to make it easier for venture capital firms to raise funds and make investments across national borders.

With a total of €90 million to spend in the area, venture capitalist Aris Constantinides speaks to Science|Business about the investment strategy.